| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/26/2007 | EP1836189A1 Novel pyridine compounds |
| 09/26/2007 | EP1836180A2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 09/26/2007 | EP1836172A1 5-ht7 receptor antagonists |
| 09/26/2007 | EP1836165A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
| 09/26/2007 | EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 09/26/2007 | CN101044121A 4-aminopyrimidine-5-one |
| 09/26/2007 | CN101044113A Substituted indole compounds, their preparation and use in medicaments |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/25/2007 | US7273940 Complex with iron, cobalt; polymerization of alpha-olefins, cyclic olefin |
| 09/25/2007 | US7273937 Process for the preparation of Tazarotene |
| 09/25/2007 | US7273886 Benzofuran inhibitors of factor VIIa |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273876 Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2403026C Process for the preparation of 6-o-propargyl erythromycin derivatives |
| 09/25/2007 | CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 09/25/2007 | CA2267928C Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105154A2 Antibiotic compounds |
| 09/20/2007 | WO2007105053A2 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | WO2007104783A2 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators |
| 09/20/2007 | WO2007104696A1 Antimalarial agents having polyaromatic structure |
| 09/20/2007 | WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 09/20/2007 | WO2007085557A3 Use of substituted 2-imidazole of imidazoline derivatives |
| 09/20/2007 | WO2007084319A3 Diaryl piperidines as cb1 modulators |
| 09/20/2007 | WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 09/20/2007 | WO2006017384A3 Indazoles useful in treating cardiovascular diseases |
| 09/20/2007 | WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors |
| 09/20/2007 | US20070219266 N-Acylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Metabolic Disorders |
| 09/20/2007 | US20070219265 Substituted gamma lactams as therapeutic agents |
| 09/20/2007 | US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 09/20/2007 | US20070219246 Dihydrobenzothiophenes |
| 09/20/2007 | US20070219198 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) for treatment of Type 2 diabetes, syndrome X, dyslipidemias, atherosclerosis, Alzheimer's and as wound healing agents; (2R)-1,1,1-trifluoro-2-[3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenyl]propan-2-ol for example |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 09/20/2007 | US20070215844 Chromene Compound |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1833824A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 09/19/2007 | EP1833822A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/19/2007 | EP1833816A1 Substituted piperidines as renin inhibitors |
| 09/19/2007 | EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 09/19/2007 | EP1833794A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 09/19/2007 | EP1740544B1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 09/19/2007 | EP1664025B1 Pyrrol derivatives with antibacterial activity |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1567519B1 Crystalline derivatives of 2-(5-chlorothien-2-yl)-n-((3s)-1((1s)-1-methyl-2-morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethensulfonamide |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | CN101039935A New piperidine antibiotics |
| 09/19/2007 | CN101039920A 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 09/19/2007 | CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 09/19/2007 | CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers |
| 09/19/2007 | CN101039912A Pyridine derivatives and the preparation and the therapeutic use thereof |
| 09/19/2007 | CN101039905A New histone deacetylases inhibitors |
| 09/19/2007 | CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101039900A 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101037433A 2-Thenoyl-3-aryl-4-acetyl-5-methyl-trans-2,3-Dihydrofuran and preparation method thereof |
| 09/19/2007 | CN101037415A S-DABO compound, synthesizing method and usage |
| 09/19/2007 | CN100338058C 新的吲哚衍生物 The new indole derivatives |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271191 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271180 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/18/2007 | US7271179 Inhibitors of JAK protein kinase |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | US7270893 Organic electroluminescent element and display |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102243A1 External pharmaceutical composition |
| 09/13/2007 | WO2007102242A1 External pharmaceutical composition |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007079199A3 Substituted bis-amide metalloprotease inhibitors |
| 09/13/2007 | WO2007030559A3 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |